Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00147550

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

A Multicenter, Open-Label, Noncomparative Phase 1-2 Clinical And Pharmacokinetic Study Of Oral PD 0325901 In Patients With Advanced Cancer

Sponsor: Pfizer

Conditions Breast Neoplasms Colonic Neoplasms Melanoma

Interventions PD-0325901

Updated 6 times since 2017 Last updated: Sep 11, 2013 Started: Feb 29, 2004 Primary completion: May 31, 2007 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

See termination reason in detailed description.

Other terminated trials from Pfizer

See all terminations from Pfizer

Other Breast Neoplasms trials with similar outcome

Browse all Breast Neoplasms trials

A PHASE1/PHASE2 clinical study on Breast Neoplasms and Colonic Neoplasms, this trial is terminated or withdrawn. The trial is conducted by Pfizer and has accumulated 6 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1_PHASE2

First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Cleveland, United States , Detroit, United States , La Jolla, United States , La Mesa, United States , Los Angeles, United States , New York, United States , Rochester, United States , San Diego, United States , Santa Monica, United States and 1 more location